Display Settings:

Format

Send to:

Choose Destination
    J Virol. 2008 Aug;82(15):7721-4. Epub 2008 May 7.

    A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters.

    Source

    Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA.

    Abstract

    The immunogenicity and protective efficacy of a live attenuated vaccine consisting of a recombinant severe acute respiratory syndrome (SARS) coronavirus lacking the E gene (rSARS-CoV-DeltaE) were studied using hamsters. Hamsters immunized with rSARS-CoV-DeltaE developed high serum-neutralizing antibody titers and were protected from replication of homologous (SARS-CoV Urbani) and heterologous (GD03) SARS-CoV in the upper and lower respiratory tract. rSARS-CoV-DeltaE-immunized hamsters remained active following wild-type virus challenge, while mock-immunized hamsters displayed decreased activity. Despite being attenuated in replication in the respiratory tract, rSARS-CoV-DeltaE is an immunogenic and efficacious vaccine in hamsters.

    PMID:
    18463152
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2493341
    Free PMC Article

    Images from this publication.See all images (3) Free text

    FIG. 1.
    FIG. 3.
    FIG. 2.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk